Tenax Therapeutics, Inc. (TENX) NASDAQ

7.00

-0.03(-0.43%)

Updated at November 10 10:26AM

Currency In USD

Valuation

Market Cap94.53M
Enterprise Value-319,147
P/E Ratio-8.79
PEG Ratio-0.14
Price/Sales Ratio15,945.94
Price/Book Ratio2.68
Enterprise/Revenue-36,785.06
Enterprise/EBITDA2.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-15,741.24
Operating Margin-25,102.17

Management Effectiveness

Return On Assets-0.3
Return On Equity-0.31

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-17.58M
Net Income-17.6M
Diluted EPS-1.15

Balance Sheet

Total Cash105.46M
Total Cash/Share2.67
Total Debt0
Total Debt/Equity0
Current Ratio41.89
Book Value Per Share2.61

Price History

52-Week Change39.8
52-Week High8.24
52-Week Low4.5
Moving Average 50 Days6.89
Moving Average 200 Days6.24

Statistics

Average Volume78,162
Shares Outstanding4.56M
% Held by Institutions5.64

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:80
Last Split DateJanuary 03, 2024